What is Aston Science?
Aston Science is a biopharmaceutical firm dedicated to developing a portfolio of novel therapeutics. Its primary focus lies in the creation of innovative medicines, with a strategic emphasis on therapeutic cancer vaccines. This specialized approach positions Aston Science at the forefront of oncology research, aiming to address unmet medical needs in cancer treatment through advanced biotechnological solutions.
How much funding has Aston Science raised?
Aston Science has raised a total of $22.7M across 1 funding round:
Series C
$22.7M
Series C (2022): $22.7M with participation from Mirae Asset Venture Investment and Timefolio Asset Management
Key Investors in Aston Science
Mirae Asset Venture Investment
Mirae Asset Venture Investment is a prominent venture capital firm known for its strategic investments in technology and life sciences sectors.
Timefolio Asset Management
Timefolio Asset Management is an investment firm that likely focuses on identifying and backing high-growth potential companies across various industries.
What's next for Aston Science?
The recent major strategic investment signals a pivotal growth phase for Aston Science. This capital infusion is expected to accelerate the advancement of its pipeline, potentially enabling the company to move through critical clinical trial stages and towards regulatory approval. The company's focus on therapeutic cancer vaccines suggests a forward-looking strategy aimed at leveraging cutting-edge immunology to combat cancer, positioning it for significant future development and market impact.
See full Aston Science company page
